PFND Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume1.00K
Average Volume (3M)N/A
Market Cap
$667.00
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.00
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding667,161,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PFND FAQ
What was Pathfinder Cell Therapy Inc’s price range in the past 12 months?
Pathfinder Cell Therapy Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Pathfinder Cell Therapy Inc’s market cap?
Pathfinder Cell Therapy Inc’s market cap is $667.00.
When is Pathfinder Cell Therapy Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pathfinder Cell Therapy Inc’s earnings last quarter?
Currently, no data Available
Is Pathfinder Cell Therapy Inc overvalued?
According to Wall Street analysts Pathfinder Cell Therapy Inc’s price is currently Overvalued.
Does Pathfinder Cell Therapy Inc pay dividends?
Pathfinder Cell Therapy Inc does not currently pay dividends.
What is Pathfinder Cell Therapy Inc’s EPS estimate?
Pathfinder Cell Therapy Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pathfinder Cell Therapy Inc have?
Pathfinder Cell Therapy Inc has 667,161,000 shares outstanding.
What happened to Pathfinder Cell Therapy Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pathfinder Cell Therapy Inc?
Currently, no hedge funds are holding shares in PFND
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pathfinder Cell Therapy Inc
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine. This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs. Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others. Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Technical Analysis
Artelo Biosciences
―
NewcelX
―
Dermata Therapeutics
―
Virax Biolabs Group Ltd. Class A
―
Azitra Inc
―